• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

QSER1与M2巨噬细胞之间的关联及肝细胞癌显著恶性特征的研究洞察

Insights into the Association Between QSER1 and M2 Macrophages and Remarkable Malignancy Characteristics in Hepatocellular Carcinoma.

作者信息

Wu Min, Shi Qi-Man, Duan Sai-Li, Ou-Yang Deng-Jie, Chen Pei, Tu Biao, Huang Peng

机构信息

Department of General Surgery, Xiangya Hospital Central South University, Changsha, Hunan, 410008, People's Republic of China.

出版信息

Int J Gen Med. 2022 Feb 18;15:1765-1775. doi: 10.2147/IJGM.S352574. eCollection 2022.

DOI:10.2147/IJGM.S352574
PMID:35210841
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8863346/
Abstract

PURPOSE

Glutamine and serine rich 1 (QSER1), as a DNA methylation modulator, play a crucial role in transforming tumor cells. Previous studies have shown that QSER1 plays a role in regulating the progression of various malignancies and that QSER1 dysfunction is connected with precancerous lesions of hepatocellular carcinoma (HCC) as well as HCC prognosis. However, little is known about the detailed contribution of QSER1 in HCC.

PATIENTS AND METHODS

Various statistical methods such as Kaplan-Meier method, AUC analysis, GSEA, and immune-infiltration analysis were used to evaluate the relationship between QSER1 expression and clinical features, prognostic factors, and potential functional mechanisms of QSER1.

RESULTS

QSER1 expression was negatively correlated with clinicopathological features (clinical stage, pathological grade, TP53 mutation, lymph node metastasis) and clinical outcome (overall survival versus recurrence). Functional enrichment analysis further suggested that QSER1 is involved in multiple pathways related to DNA replication and tumor immunity. TIMER analysis indicated that high QSER1 expression was significantly associated with higher macrophage infiltration and poorer macrophage-related outcomes. In particular, QSER1 was significantly more associated with M2 macrophages than M1 macrophages.

CONCLUSION

Overall, elevated QSER1 is a potential prognostic marker for HCC and is associated with immune infiltration in HCC.

摘要

目的

富含谷氨酰胺和丝氨酸1(QSER1)作为一种DNA甲基化调节剂,在肿瘤细胞转化中起关键作用。先前的研究表明,QSER1在调节各种恶性肿瘤的进展中起作用,并且QSER1功能障碍与肝细胞癌(HCC)的癌前病变以及HCC预后相关。然而,关于QSER1在HCC中的具体作用知之甚少。

患者和方法

使用多种统计方法,如Kaplan-Meier法、AUC分析、GSEA和免疫浸润分析,来评估QSER1表达与临床特征、预后因素以及QSER1潜在功能机制之间的关系。

结果

QSER1表达与临床病理特征(临床分期、病理分级、TP53突变、淋巴结转移)和临床结局(总生存与复发)呈负相关。功能富集分析进一步表明,QSER1参与多个与DNA复制和肿瘤免疫相关的途径。TIMER分析表明,高QSER1表达与更高的巨噬细胞浸润以及更差的巨噬细胞相关结局显著相关。特别是,QSER1与M2巨噬细胞的相关性明显高于M1巨噬细胞。

结论

总体而言,QSER1升高是HCC的潜在预后标志物,并且与HCC中的免疫浸润相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5831/8863346/9d5dc654d8d6/IJGM-15-1765-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5831/8863346/c3d92cf905ad/IJGM-15-1765-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5831/8863346/0b7244664e18/IJGM-15-1765-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5831/8863346/a93cd02c9a3b/IJGM-15-1765-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5831/8863346/9d5dc654d8d6/IJGM-15-1765-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5831/8863346/c3d92cf905ad/IJGM-15-1765-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5831/8863346/0b7244664e18/IJGM-15-1765-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5831/8863346/a93cd02c9a3b/IJGM-15-1765-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5831/8863346/9d5dc654d8d6/IJGM-15-1765-g0004.jpg

相似文献

1
Insights into the Association Between QSER1 and M2 Macrophages and Remarkable Malignancy Characteristics in Hepatocellular Carcinoma.QSER1与M2巨噬细胞之间的关联及肝细胞癌显著恶性特征的研究洞察
Int J Gen Med. 2022 Feb 18;15:1765-1775. doi: 10.2147/IJGM.S352574. eCollection 2022.
2
MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma.MARCKS 在肿瘤相关巨噬细胞中与免疫浸润和肝癌不良预后相关。
Cancer Invest. 2021 Oct;39(9):756-768. doi: 10.1080/07357907.2021.1950757. Epub 2021 Jul 19.
3
High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.PDZ 结合激酶高表达与肝癌预后不良和免疫浸润相关。
World J Surg Oncol. 2022 Jan 22;20(1):22. doi: 10.1186/s12957-021-02479-w.
4
Immune infiltration-associated serum amyloid A1 predicts favorable prognosis for hepatocellular carcinoma.免疫浸润相关血清淀粉样蛋白 A1 预测肝细胞癌预后良好。
World J Gastroenterol. 2020 Sep 21;26(35):5287-5301. doi: 10.3748/wjg.v26.i35.5287.
5
Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.肝细胞癌中 COMMD 蛋白家族的表达、预后价值和免疫浸润活性的转录分析。
BMC Cancer. 2021 Sep 7;21(1):1001. doi: 10.1186/s12885-021-08699-3.
6
Hydroxysteroid 17-Beta Dehydrogenase 6 Is a Prognostic Biomarker and Correlates with Immune Infiltrates in Hepatocellular Carcinoma.羟甾体 17-β 脱氢酶 6 是肝癌的预后生物标志物,并与免疫浸润相关。
Dig Dis Sci. 2022 Jan;67(1):146-158. doi: 10.1007/s10620-021-06832-7. Epub 2021 Jan 26.
7
DCK is a promising prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma.DCK是一种很有前景的预后生物标志物,与肝细胞癌中的免疫浸润相关。
World J Surg Oncol. 2020 Jul 20;18(1):176. doi: 10.1186/s12957-020-01953-1.
8
Downregulation of GNA14 in hepatocellular carcinoma indicates an unfavorable prognosis.肝细胞癌中GNA14的下调表明预后不良。
Oncol Lett. 2020 Jul;20(1):165-172. doi: 10.3892/ol.2020.11538. Epub 2020 Apr 15.
9
High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis.高迁移率族蛋白盒1表达与肝细胞癌合并肝硬化患者的瘤周巨噬细胞浸润及不良预后相关。
BMC Cancer. 2016 Nov 11;16(1):880. doi: 10.1186/s12885-016-2883-z.
10
Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.应激诱导蛋白激酶 CK1 Delta 的上调与肝细胞癌患者预后不良相关。
Genet Test Mol Biomarkers. 2021 Jul;25(7):504-514. doi: 10.1089/gtmb.2020.0093.

引用本文的文献

1
Shedding a Light on Dark Genes: A Comparative Expression Study of Orthologues during Zebrafish Development.揭示神秘基因:斑马鱼发育过程中直系同源基因的比较表达研究
Genes (Basel). 2024 Apr 15;15(4):492. doi: 10.3390/genes15040492.

本文引用的文献

1
Immunotherapies for hepatocellular carcinoma.肝细胞癌的免疫疗法
Nat Rev Clin Oncol. 2022 Mar;19(3):151-172. doi: 10.1038/s41571-021-00573-2. Epub 2021 Nov 11.
2
Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer.对整个转录组进行生存分析可识别出乳腺癌中具有最高预后能力的生物标志物。
Comput Struct Biotechnol J. 2021 Jul 18;19:4101-4109. doi: 10.1016/j.csbj.2021.07.014. eCollection 2021.
3
DUSP12 regulates the tumorigenesis and prognosis of hepatocellular carcinoma.
双特异性磷酸酶12调节肝细胞癌的肿瘤发生和预后。
PeerJ. 2021 Aug 3;9:e11929. doi: 10.7717/peerj.11929. eCollection 2021.
4
Investigation of Potential Molecular Biomarkers for Diagnosis and Prognosis of AFP-Negative HCC.甲胎蛋白阴性肝癌诊断与预后潜在分子生物标志物的研究
Int J Gen Med. 2021 Aug 10;14:4369-4380. doi: 10.2147/IJGM.S323868. eCollection 2021.
5
Exploring liver cancer biology through functional genetic screens.通过功能基因筛选探索肝癌生物学
Nat Rev Gastroenterol Hepatol. 2021 Oct;18(10):690-704. doi: 10.1038/s41575-021-00465-x. Epub 2021 Jun 23.
6
Advances in immunotherapy for hepatocellular carcinoma.肝细胞癌的免疫治疗进展。
Nat Rev Gastroenterol Hepatol. 2021 Aug;18(8):525-543. doi: 10.1038/s41575-021-00438-0. Epub 2021 Apr 13.
7
QSER1 protects DNA methylation valleys from de novo methylation.QSER1 保护 DNA 甲基化谷免于从头甲基化。
Science. 2021 Apr 9;372(6538). doi: 10.1126/science.abd0875.
8
TANK-Binding Kinase 1 (TBK1) Serves as a Potential Target for Hepatocellular Carcinoma by Enhancing Tumor Immune Infiltration.TANK 结合激酶 1(TBK1)通过增强肿瘤免疫浸润,可作为肝细胞癌的潜在靶点。
Front Immunol. 2021 Feb 18;12:612139. doi: 10.3389/fimmu.2021.612139. eCollection 2021.
9
CMTM8 as an LPA1-associated partner mediates lysophosphatidic acid-induced pancreatic cancer metastasis.作为与LPA1相关的伴侣蛋白,CMTM8介导溶血磷脂酸诱导的胰腺癌转移。
Ann Transl Med. 2021 Jan;9(1):42. doi: 10.21037/atm-20-1013.
10
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.